182 related articles for article (PubMed ID: 16670322)
1. HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.
Turnbull EL; Lopes AR; Jones NA; Cornforth D; Newton P; Aldam D; Pellegrino P; Turner J; Williams I; Wilson CM; Goepfert PA; Maini MK; Borrow P
J Immunol; 2006 May; 176(10):6130-46. PubMed ID: 16670322
[TBL] [Abstract][Full Text] [Related]
2. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
3. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response.
van Bockel DJ; Price DA; Munier ML; Venturi V; Asher TE; Ladell K; Greenaway HY; Zaunders J; Douek DC; Cooper DA; Davenport MP; Kelleher AD
J Immunol; 2011 Jan; 186(1):359-71. PubMed ID: 21135165
[TBL] [Abstract][Full Text] [Related]
4. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
[TBL] [Abstract][Full Text] [Related]
5. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
6. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
[TBL] [Abstract][Full Text] [Related]
7. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.
Altfeld M; Kalife ET; Qi Y; Streeck H; Lichterfeld M; Johnston MN; Burgett N; Swartz ME; Yang A; Alter G; Yu XG; Meier A; Rockstroh JK; Allen TM; Jessen H; Rosenberg ES; Carrington M; Walker BD
PLoS Med; 2006 Oct; 3(10):e403. PubMed ID: 17076553
[TBL] [Abstract][Full Text] [Related]
8. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure.
Ngumbela KC; Day CL; Mncube Z; Nair K; Ramduth D; Thobakgale C; Moodley E; Reddy S; de Pierres C; Mkhwanazi N; Bishop K; van der Stok M; Ismail N; Honeyborne I; Crawford H; Kavanagh DG; Rousseau C; Nickle D; Mullins J; Heckerman D; Korber B; Coovadia H; Kiepiela P; Goulder PJ; Walker BD
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):72-82. PubMed ID: 18275350
[TBL] [Abstract][Full Text] [Related]
9. Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians.
Currier JR; Harris ME; Cox JH; McCutchan FE; Birx DL; Maayan S; Ferrari G
AIDS Res Hum Retroviruses; 2005 Mar; 21(3):239-45. PubMed ID: 15795531
[TBL] [Abstract][Full Text] [Related]
10. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
[TBL] [Abstract][Full Text] [Related]
11. Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.
Newberg MH; McEvers KJ; Gorgone DA; Lifton MA; Baumeister SH; Veazey RS; Schmitz JE; Letvin NL
J Immunol; 2006 Jan; 176(1):319-28. PubMed ID: 16365424
[TBL] [Abstract][Full Text] [Related]
12. Despite biased TRBV gene usage against a dominant HLA B57-restricted epitope, TCR diversity can provide recognition of circulating epitope variants.
Simons BC; Vancompernolle SE; Smith RM; Wei J; Barnett L; Lorey SL; Meyer-Olson D; Kalams SA
J Immunol; 2008 Oct; 181(7):5137-46. PubMed ID: 18802118
[TBL] [Abstract][Full Text] [Related]
13. Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.
Gillespie GM; Stewart-Jones G; Rengasamy J; Beattie T; Bwayo JJ; Plummer FA; Kaul R; McMichael AJ; Easterbrook P; Dong T; Jones EY; Rowland-Jones SL
J Immunol; 2006 Sep; 177(6):3893-902. PubMed ID: 16951352
[TBL] [Abstract][Full Text] [Related]
14. Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became Infected.
Boppana S; Fiore-Gartland A; Bansal A; Goepfert P
J Virol; 2020 Jan; 94(2):. PubMed ID: 31645444
[TBL] [Abstract][Full Text] [Related]
15. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.
Douek DC; Betts MR; Brenchley JM; Hill BJ; Ambrozak DR; Ngai KL; Karandikar NJ; Casazza JP; Koup RA
J Immunol; 2002 Mar; 168(6):3099-104. PubMed ID: 11884484
[TBL] [Abstract][Full Text] [Related]
17. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.
Ladell K; Hashimoto M; Iglesias MC; Wilmann PG; McLaren JE; Gras S; Chikata T; Kuse N; Fastenackels S; Gostick E; Bridgeman JS; Venturi V; Arkoub ZA; Agut H; van Bockel DJ; Almeida JR; Douek DC; Meyer L; Venet A; Takiguchi M; Rossjohn J; Price DA; Appay V
Immunity; 2013 Mar; 38(3):425-36. PubMed ID: 23521884
[TBL] [Abstract][Full Text] [Related]
18. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
19. Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.
Kunwar P; Hawkins N; Dinges WL; Liu Y; Gabriel EE; Swan DA; Stevens CE; Maenza J; Collier AC; Mullins JI; Hertz T; Yu X; Horton H
PLoS One; 2013; 8(5):e64405. PubMed ID: 23741326
[TBL] [Abstract][Full Text] [Related]
20. Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality.
Mkhwanazi N; Thobakgale CF; van der Stok M; Reddy S; Mncube Z; Chonco F; Walker BD; Altfeld M; Goulder PJ; Ndung'u T
Virology; 2010 Sep; 405(2):483-91. PubMed ID: 20638093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
